Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Old Republic presents a balanced investment case. Second-quarter 2026 consolidated premiums and fees grew 5.2%, Title Insurance premiums and fees grew 10.7%, net investment income increased 6.1%, and book value per share reached $25.33. Conversely, quarterly net operating income declined 11.1%, the consolidated combined ratio rose to 95.3%, and Specialty Insurance underwriting income fell 50.5%, including approximately $40 million of unfavorable transactional-risk reserve development. The 45-year regular-dividend growth record and expected earnings accretion from Everett Cash Mutual support the long-term case, but current underwriting and expense pressure warrants a Hold rather than a more favorable recommendation.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets2 analysts · as of 18 Aug 2026
Low · most bearish analyst$39.00
Mean target$43.50
High · most bullish analyst$48.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$39.0024%

Adverse reserve development broadens beyond the run-off transactional-risk business, startup and technology costs keep the expense ratio elevated, and Specialty Insurance remains above its full-cycle combined-ratio target. Continued year-over-year operating-income declines would outweigh Title Insurance and investment-income growth.

Base CaseCentral scenario
$43.5053%
Matches the consensus mean

Premium growth, investment income, Title Insurance improvement, and dividend growth broadly offset weaker Specialty Insurance underwriting and lower reserve benefits.

Bull CaseUpside scenario
$48.0023%

Title Insurance sustains double-digit premium growth and improves operating leverage, Specialty Insurance returns within its 90%-95% full-cycle combined-ratio target, and Everett Cash Mutual contributes the earnings accretion management expects. Continued investment-income growth and regular-dividend growth would add further support.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Title Insurance delivered 10.7% second-quarter premium-and-fee growth, a 95.1% combined ratio versus 99.0% a year earlier, and a 130.5% increase in pretax operating income.
  • Net investment income increased 6.1% year over year in the second quarter, supported by a higher invested-asset base.
  • The regular dividend is projected at $1.26 per share for 2026, 8.6% above 2025, marking 45 consecutive annual increases and 85 years of uninterrupted regular payments.
Sign in / Sign up to read more
Key Investment Risks
  • Second-quarter net operating income declined 11.1% and diluted net operating EPS declined 9.3% year over year.
  • Specialty Insurance underwriting income declined 50.5%, while approximately $40 million of unfavorable run-off transactional-risk reserve development added 3.0 points to its quarterly loss ratio.
  • Specialty Insurance expenses remain elevated because of startup companies, technology modernization, data and analytics, artificial intelligence, and overlapping amortization before legacy systems are retired.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.